Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06134154 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Carbon Dioxide Gas for Endoscopy

A NA study of Abdominal Pain, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT06134154 is a NA study of Abdominal Pain that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 350 participants, above the 132-participant average among 19 other Abdominal Pain trials with a reported enrollment target (165% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06134154, a NA study of Abdominal Pain, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare the efficacy and safety of air versus carbon dioxide gas insufflation for endoscopy in children. The main question\[s\] it aims to answer are: •to determine safety of CO2 Assess patient comfort (abdominal pain, flatulence and bloating) with CO2 use when compared to air.

Conditions Studied

Interventions

  • OTHER Endoscopic insufflation gas

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2024-01-24
Est. Completion 2028-12
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06134154

The ClinicalTrials.gov registry entry for NCT06134154 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 132-participant average among 19 other Abdominal Pain trials with a reported enrollment target (165% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abdominal Pain appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic insufflation gas is the first listed.

NCT06134154 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06134154 about?

NCT06134154 is a clinical study titled "Safety and Efficacy of Carbon Dioxide Gas for Endoscopy". The goal of this clinical trial is to compare the efficacy and safety of air versus carbon dioxide gas insufflation for endoscopy in children. The main question\[s\] it aims to answer are: •to determine safety of CO2 Assess patient comfort (abdominal pain, flatulence and bloating) with CO2 use whe...

What is the current status of trial NCT06134154?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-01-24. Estimated completion is 2028-12.

What conditions does trial NCT06134154 study?

This clinical trial studies the following conditions: Abdominal Pain.

What interventions are being tested in trial NCT06134154?

The interventions under investigation include: Endoscopic insufflation gas (OTHER).

Who is sponsoring clinical trial NCT06134154?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06134154 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.